Brief: TScan Therapeutics Announces Pricing Of 22.9 Million Shares Of Its Voting Common Stock At A Public Offering Price Of $2.00 Per Share
26/05/2023 05:39
May 26 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ANNOUNCES PRICING OF $140 MILLION
PUBLIC
OFFERING
* TSCAN THERAPEUTICS INC - PRICING OF 22.9 MILLION SHARES
OF ITS
VOTING COMMON STOCK AT A PUBLIC OFFERING PRICE OF $2.00 PER
SHARE
Source text for Eikon: ID:nGNX97BxTx
Further company coverage: TCRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing